Dendritic Nanotechnologies
Stage
Seed | AliveAbout Dendritic Nanotechnologies
DNT is a developer and provider of advanced dendritic polymers. DNT aims to provide business partners with dendrimer technologies and commercialization services based on its new Priostar dendrimer technologies.
Missing: Dendritic Nanotechnologies's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Dendritic Nanotechnologies's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Dendritic Nanotechnologies Patents
Dendritic Nanotechnologies has filed 4 patents.

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
12/16/2016 | 4/20/2021 | Acetylcholinesterase inhibitors, Fungicides, Organophosphate insecticides, Herbicides, Insecticides | Grant |
Application Date | 12/16/2016 |
---|---|
Grant Date | 4/20/2021 |
Title | |
Related Topics | Acetylcholinesterase inhibitors, Fungicides, Organophosphate insecticides, Herbicides, Insecticides |
Status | Grant |
Dendritic Nanotechnologies Frequently Asked Questions (FAQ)
Where is Dendritic Nanotechnologies's headquarters?
Dendritic Nanotechnologies's headquarters is located at 2625 Denison Drive, Mount Pleasant.
What is Dendritic Nanotechnologies's latest funding round?
Dendritic Nanotechnologies's latest funding round is Seed.
Who are the investors of Dendritic Nanotechnologies?
Investors of Dendritic Nanotechnologies include Central Michigan University Research Corporation.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.